Foxborough, MA, United States of America

Melanie P Gygi

This inventor holds 1 USPTO granted patent. Top assignee: Whitehead Institute for Biomedical Research. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Melanie P Gygi. Retrieved from https://idiyas.com/inventor/melanie-p-gygi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Melanie P. Gygi

Introduction

Melanie P. Gygi is a prominent inventor based in Foxborough, MA (US). She has made significant contributions to the field of biomedical research, particularly in the modulation of mTORC1 activity. Her work is crucial for understanding and treating diseases characterized by aberrant mTORC1 activity.

Latest Patents

Melanie holds 1 patent titled "Methods of identifying modulators of CASTOR1-GATOR2 interaction and use of same to modulate mTORC1." This invention relates to methods for identifying compounds that can modulate mTORC1 activity in a cell by influencing the activity of CASTOR1. The identified compounds have potential applications in the treatment of various diseases and conditions linked to mTORC1 dysregulation.

Career Highlights

Melanie is affiliated with the Whitehead Institute for Biomedical Research, where she conducts her research. Her work has garnered attention for its innovative approach to understanding cellular mechanisms and their implications for health.

Collaborations

Some of her notable coworkers include David Sabatini and Lynne Chantranupong, who have also made significant contributions to the field of biomedical research.

Conclusion

Melanie P. Gygi's innovative work in identifying modulators of mTORC1 activity highlights her important role in advancing biomedical research. Her contributions are paving the way for new therapeutic strategies in treating diseases associated with mTORC1 dysregulation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…